Get started
Author

V. Picone

Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest
2007 · Alfredo Falcone, Sergio Ricci, et al. · Journal of Clinical Oncology · 1,241
PDF
The triplet combination of irinotecan, oxaliplatin and 5FU/LV (FOLFOXIRI) vs the doublet of irinotecan and 5FU/LV (FOLFIRI) as first-line treatment of metastatic colorectal cancer (MCRC): Results of a randomized phase III trial by the Gruppo Oncologico Nord Ovest (G.O.N.O.)
2006 · A. Falcone, G. Masi, et al. · Journal of Clinical Oncology · 25
Weekly Vinorelbine and Docetaxel as Second-Line Chemotherapy for Pretreated Non-Small Cell Lung Cancer Patients: a Phase I-II Trial
2004 · F. Nelli, G. Naso, et al. · Journal of Chemotherapy · 13
Rheumatic Diseases Development in Patients Treated by Anti-PD1 Immune Checkpoint Inhibitors: A Single-Centre Descriptive Study
2023 · Fulvia Ceccarelli, Francesco Natalucci, et al. · Life · 9
PDF
Antinuclear antibodies may predict the development of immune-related adverse events in asymptomatic patients treated with immune checkpoint inhibitors: results from a single-center cohort
2024 · Fulvia Ceccarelli, Francesco Natalucci, et al. · Clinical and Experimental Medicine · 8
PDF
Systemic treatment of mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer—single versus double checkpoint inhibition
2024 · D. Marinelli, A. Sabatini, et al. · ESMO Open · 4
Intensified Total Neoadjuvant Therapy Versus Intensified Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Propensity Score Matching Analysis
2022 · FRANCESCA DE FELICE, DANIELA MUSIO, et al. · Anticancer Research · 2
Randomized phase III study of FOLFOXIRI (irinotecan, oxaliplatin and infusional 5FU/LV) vs FOLFIRI (irinotecan and 5FU/LV) as first-line treatment of metastatic colorectal cancer (MCRC): Subgroup and multivariate analysis
2007 · Alfredo Falcone, M. Andreuccetti, et al. · CINECA IRIS Institutial research information system (University of Pisa) · 2
Brain Metastasis From Anal Canal Squamous Cell Carcinoma: A Rare Case Report and Systematic Review
2026 · Miriam Tomaciello, Mauro Palmieri, et al. · Clinical Colorectal Cancer · 1
Clinicomics for Predicting HER2 Expression in Metastatic Colorectal Cancer: A Multicenter Machine Learning Analysis on Real-World Data
2025 · Vincenzo Formica, Cristina Morelli, et al. · Oncology · 1
Bidirectional Neoadjuvant Chemotherapy for Patients with Gastric Cancer and Synchronous Peritoneal Metastases (GCPMs): Results of a Western Phase II Study
2025 · Daniele Biacchi, Marco Angrisani, et al. · Journal of Clinical Medicine · 1
PDF
Phase II study of sequential chemotherapy with cisplatin (P) in combination with infusional 5FU/LV (PFL) followed by irinotecan (Ir) + 5FU/LV (IrFL) followed by docetaxel (T) + 5FU/LV (TFL) in patients (pts) with metastatic gastric carcinoma (MGC) by the Gruppo Oncologio Nord-Ovest (GONO)
2007 · F. Loupakis, G. Masi, et al. · Journal of Clinical Oncology · 1
International survey on neoadjuvant treatments in anatomically resectable pancreatic adenocarcinoma (INSPIRA): a real-life snapshot
2026 · Chiara D'Alterio, Quirino Lai, et al. · Surgical Oncology
132P Timing and treatment modality outweigh disease extent in hepatic locoregional therapy for metastatic colon cancer: A real-world analysis
2026 · C. Cataldi, C. Capasso, et al. · Annals of Oncology
637eP Real-world perioperative FLOT in gastric and gastroesophageal adenocarcinoma: Outcomes and prognostic factors from an Italian three-centre study
2026 · C. Cataldi, C. Capasso, et al. · Annals of Oncology
PDF
85P Focus on HER2-positive metastatic colorectal cancer (HER2+ mCRC): A real-world retrospective analysis
2024 · M.A. Calegari, V. Formica, et al. · Annals of Oncology
PDF
258P The impact of total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC): A real-world Italian multicentric experience
2024 · F. Lo Prinzi, V. Picone, et al. · Annals of Oncology
PDF
Anatomic site of metastases can influence response to nivolumab in NSCLC patients.
2018 · Andrea Botticelli, Bruna Cerbelli, et al. · Journal of Clinical Oncology
Sequential treatment with cisplatin (P) in combination with infusional 5-FU/LV (PFL) followed by Irinotecan (IR) + 5-FU/LV (IRFL) followed by Docetaxel (T) + 5-FU/LV (TFL) in patients (PTS) with metastatic (M) gastric carcinoma (GC): preliminary results of a phase II trial by the Gruppo Oncologico Nord Ovest (G.O.N.O.)
2006 · Fotios Loupakis, Gianluca Masi, et al. · CINECA IRIS Institutial research information system (University of Pisa)
Folfoxiri improves survival compared to folfiri as first-line treatment of metastatic colorectal cancer (MCRC): updated results of a randomized phase III study by the Gruppo Oncologico Nord Ovest (G.O.N.O.)
2006 · Gianluca Masi, C. Barbara, et al. · CINECA IRIS Institutial research information system (University of Pisa)
Works count: 20
Citation count: 1,308
H-index: 5
I10-index: 3
Year
Topic
Type